Hologic Inc (HOLX) 33.99 $HOLX
33.0% Return Seen to Date on SmarTrend Hologic Call (HOLX)
Comtex SmarTrend(R) - Mon Apr 20, 4:57PM CDT
SmarTrend identified an Uptrend for Hologic (NASDAQ:HOLX) on October 24th, 2014 at $24.87. In approximately 6 months, Hologic has returned 33.01% as of today's recent price of $33.08.
HOLX: 33.99 (+0.57)
Mammography Equipment (Analog & Digital) Market 2015-2020 - Global Strategic Business Report
M2 - Fri Apr 17, 3:49AM CDT
Research and Markets (http://www.researchandmarkets.com/research/svw6ds/mammography) has announced the addition of the "Mammography Equipment - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Mammography Equipment in US$ Thousands by the following Product Segments: Analog Mammography Equipment, and Digital Mammography Equipment. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. The report profiles 26 companies including many key and niche players such as: - Fujifilm Corporation (Japan) - GE Healthcare (The UK) - Hologic, Inc. (US) - I.M.S. (Internazional Medico Scientifica) srl (Italy) - Metaltronica SpA (Italy) - Philips Healthcare (The Netherlands) - Planmed Oy (Finland) - Siemens Healthcare (Germany) - Toshiba Medical Systems Corp. (Japan) Key Topics Covered: 1. INDUSTRY OVERVIEW 2. TRENDS AND ISSUES 3. 3D MAMMOGRAPHY MARKET 4. COMPETITIVE LANDSCAPE 5. MAMMOGRAPHY - AN OVERVIEW 6. COMPLEMENTARY CANCER DIAGNOSTIC TECHNOLOGIES 7. BREAST CANCER - A BACKDROP 8. PRODUCT INTRODUCTIONS/APPROVALS 9. RECENT INDUSTRY ACTIVITY 10. FOCUS ON SELECT PLAYERS 11. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 26 (including Divisions/Subsidiaries - 31) - The United States (15) - Canada (1) - Japan (3) - Europe (12) - - Germany (2) - - The United Kingdom (1) - - Rest of Europe (9) For more information visit http://www.researchandmarkets.com/research/sv...ammography
HOLX: 33.99 (+0.57)
Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology
PR Newswire - Thu Apr 16, 3:10PM CDT
Hologic, Inc. (NASDAQ: HOLX) today commented on an important cervical cancer screening studyi published on-line this week in Cancer Cytopathology, a peer-reviewed journal of the American Cancer Society.
HOLX: 33.99 (+0.57)
Cyberonics-Sorin $2.7B Deal Gets US Antitrust Go-Ahead - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 15, 1:30PM CDT
Cyberonics, Inc. (CYBX) declared that it has received the U.S. Antitrust go-ahead for the $2.7 billion deal.
ABMD: 68.83 (-0.74), LMNX: 16.10 (-0.18), HOLX: 33.99 (+0.57), CYBX: 62.89 (-0.30)
Is Great Basin Scientific Just Another Pump And Dump?
The GeoTeam - Seeking Alpha - Wed Apr 08, 12:57PM CDT
GeoInvesting is currently short Great Basic Scientific (NASDAQ: GBSN ), a rapid diagnostic medical test (Nucleic Acid Assay Testing) firm. We first alerted GeoInvesting premium members that we identified red flags associated with GBSN on March 30,...
GNMK: 10.69 (-0.24), GBSN: 4.17 (-0.53), BDX: 144.33 (-0.02), VIVO: 19.13 (+0.33), QDEL: 23.38 (-0.43), CPHD: 58.97 (+5.67), TTOO: 16.92 (-0.56), QGEN: 24.83 (-0.07), HOLX: 33.99 (+0.57), NSPH: 4.04 (+0.04)
Luxembourg National Health Laboratory Adopts Hologic's World Class Cervical Health Solutions for Screening Programme
PR Newswire Europe - Wed Apr 08, 2:00AM CDT
-- Improved sample quality, workflow efficiencies and flexibility drive transition to Hologic platform
HOLX: 33.99 (+0.57)
Diagnostic Imaging Technologies Global Market Report 2015 - Forecast to 2020
M2 - Tue Apr 07, 11:29AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dn9vr2/diagnostic) has announced the addition of the "Diagnostic Imaging Technologies Global Market - Forecast to 2020" report to their offering. The global diagnostic imaging market is expected to reach approximately $27.1 billion with a CAGR of 4.7% in coming five years. Diagnostic imaging is being identified as one of the fastest growing market of all healthcare sectors. Advances in diagnostic imaging technology have redefined how physicians diagnose and treat some of the most life threatening diseases such as cancer and heart disease and they have nearly eliminated the need for exploratory surgery. Imaging techniques would be therefore able us to diagnose, treat and cure patients without causing any harmful side effects. The different diagnostic imaging modalities include X-ray systems, Computed Tomography (CT) Scanners, Magnetic Resonance Imaging (MRI) systems, Ultrasound systems and Nuclear imaging systems. Globally among the diagnostic imaging techniques, X-ray is the most frequently used imaging procedure with more than 100 million X-ray exams per year followed by MRI, PET, SPECT, CT and nuclear medicine. This indicates that diagnostic imaging market contributes to its highest share among all imaging techniques. There are many factors involved in driving the growth of the diagnostic imaging market such as emerging applications in diagnostic procedures, high prevalence of the diseases, ongoing research activities all over the world and most important thing, awareness in people about the use of early disease diagnosis. On the other hand the high cost of the diagnostic imaging systems, risk of the radiation exposure, shortage of helium for MRI systems, poor healthcare insurance coverage, particularly for the diagnostic procedures are restricting the market growth. North America holds the largest share in the global diagnostic imaging market, followed by Europe. However, the Asia-Pacific market is expected to grow at the fastest CAGR in the coming five years. The Asian and Latin American countries represent the fastest growing markets due to increasing government support for research and rising industry and academic partnerships for pre-clinical research. But still the factors like economic slowdown, pricing pressures may compel the companies to focus on Asian markets. The top key market players in the global diagnostic imaging market are GE Healthcare, Philips Healthcare, Siemens Healthcare, Toshiba Medical Systems Corporation, Hitachi Medical Corporation, Carestream Health, Inc., Esaote S.P.A, Hologic, Inc., Samsung Medison and Shimadzu Corporation. Among them GE Healthcare (U.K.) held the leadership position in the global market by launching many new products into the market. Key Topics Covered: 1 Executive Summary 2 Introduction 3 Market Analysis 4 Diagnostic Imaging Technologies Global Market, By Products 5 Global Diagnostic Imaging Market, Technology Outlook 6 Diagnostic Imaging Technologies Global Market, Applications Outlook 7 Diagnostic Imaging Technologies Global Market, By End-Users 8 Regional Market Analysis 9 Company Developments 10 Major Player Profiles - Carestream Health, Inc. - Esaote S.P.A - GE Healthcare - Hitachi Medical Corporation - Hologic, Inc - Philips Healthcare - Samsung Medison - Shimadzu Corporation - Siemens Healthcare - Toshiba Medical Systems Corporation For more information visit http://www.researchandmarkets.com/research/dn9vr2/diagnostic
MDSY: 2.50 (-0.06), HOLX: 33.99 (+0.57)
Hologic to Announce Financial Results for the Second Quarter of Fiscal 2015 on Wednesday, April 29, 2015
PR Newswire - Mon Apr 06, 3:01PM CDT
Hologic, Inc. (NASDAQ: HOLX) announced today that the Company plans to release its operating results for the second quarter of fiscal 2015 on Wednesday, April 29, 2015, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time.
HOLX: 33.99 (+0.57)
Uptrend Call Working As Hologic Stock Rises 33.0% (HOLX)
Comtex SmarTrend(R) - Mon Apr 06, 10:10AM CDT
SmarTrend identified an Uptrend for Hologic (NASDAQ:HOLX) on October 24th, 2014 at $24.87. In approximately 5 months, Hologic has returned 33.01% as of today's recent price of $33.08.
HOLX: 33.99 (+0.57)
IDEXX Banks on Strong CAG, Global Growth Continues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 01, 3:15PM CDT
On Mar 31 2015, we issued an updated research report on IDEXX Laboratories, Inc. (IDXX).
ABMD: 68.83 (-0.74), EW: 138.33 (-3.59), IDXX: 164.05 (+4.65), HOLX: 33.99 (+0.57)
Hologic Delivers Notice that Holders of 2.00% Convertible Exchange Senior Notes Due 2037 are Eligible to Convert
PR Newswire - Wed Apr 01, 3:01PM CDT
Hologic, Inc. (NASDAQ: HOLX) announced today that it has notified holders of the 2.00% Convertible Exchange Senior Notes due 2037 (CUSIP No. 436440 AB7) issued November 23, 2010, and Wilmington Trust Company, the trustee, paying agent and conversion agent for the notes, that holders are eligible to convert the notes. This conversion right is subject to the terms of the base indenture governing the notes dated as of December 10, 2007, as supplemented by the second supplemental indenture dated as of November 23, 2010 (collectively, the indenture).
HOLX: 33.99 (+0.57)
Health Care Equipment Stocks Technical Data -- Boston Scientific, Abbott Laboratories, Zimmer Holdings, Hologic, and Accuray
PR Newswire - Wed Apr 01, 7:35AM CDT
Editor Note: For more information about this release, please scroll to bottom.
ZMH: 118.76 (+0.19), BSX: 18.34 (-0.08), ABT: 48.32 (-0.14), ARAY: 9.11 (-0.11), HOLX: 33.99 (+0.57)
Hologic Has Returned 32.0% Since SmarTrend Recommendation (HOLX)
Comtex SmarTrend(R) - Mon Mar 30, 9:24AM CDT
SmarTrend identified an Uptrend for Hologic (NASDAQ:HOLX) on October 24th, 2014 at $24.87. In approximately 5 months, Hologic has returned 31.97% as of today's recent price of $32.82.
HOLX: 33.99 (+0.57)
Zacks Industry Outlook Highlights: Boston Scientific, Edwards Lifesciences, Natus Medical, Hologic and Abiomed - Press Releases
Zacks Equity Research - Zacks Investment Research - Fri Mar 27, 8:30AM CDT
Zacks Industry Outlook Highlights: Boston Scientific, Edwards Lifesciences, Natus Medical, Hologic and Abiomed
BSX: 18.34 (-0.08), ABMD: 68.83 (-0.74), BABY: 42.15 (-0.01), EW: 138.33 (-3.59), HOLX: 33.99 (+0.57)
MedTech M&As Continue Regardless of Tax Scenarios - Industry Outlook
Zacks Equity Research - Zacks Investment Research - Thu Mar 26, 3:28PM CDT
MedTech M&As Continue Regardless of Tax Scenarios - Industry Outlook
ABMD: 68.83 (-0.74), BDX: 144.33 (-0.02), MDT: 77.61 (-0.89), ILMN: 189.59 (-3.01), TRNX: 26.25 (+0.01), ARAY: 9.11 (-0.11), NUVA: 43.99 (+0.23), HSP: 87.61 (-0.05), BSX: 18.34 (-0.08), BABY: 42.15 (-0.01), SNN: 35.76 (+0.44), JNJ: 101.08 (+0.62), WMGI: 26.26 (-0.03), IART: 61.31 (+0.84), SWM: 45.62 (+0.16), SYK: 96.90 (-0.28), ZMH: 118.76 (+0.19), ABT: 48.32 (-0.14), ALGN: 59.18 (+3.17), EW: 138.33 (-3.59), MYL: 76.06 (+2.37), ABAX: 63.62 (+0.31), STE: 70.76 (+0.06), GILD: 103.69 (-1.52), BAX: 71.14 (-0.37), DGX: 75.81 (+0.60), STJ: 73.47 (-0.54), LH: 126.93 (+0.55), HOLX: 33.99 (+0.57)
Computer Aided Detection (CAD) - Global Strategic Business Report 2015-2020: CAD Use Rises despite Controversies
M2 - Thu Mar 26, 6:32AM CDT
Research and Markets (http://www.researchandmarkets.com/research/x45l84/computer_aided) has announced the addition of the "Computer Aided Detection (CAD) - Global Strategic Business Report" report to their offering. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. This report analyzes the US and European markets for Computer Aided Detection (CAD) in US$ Thousands by the following Application Segments - Breast, Chest, and Others. The US market is also analysed in Number of Units for the above Application Segments. The report also provides a consolidated, single-segment volume analysis for the European market. The report profiles 29 companies including many key and niche players such as: - EDDA Technology, Inc. (US) - Hologic, Inc. (US) - iCAD, Inc. (US) - Invivo Corp. (US) - Merge Healthcare, Inc. (US) - Riverain Technologies (US) - Salient Imaging, Inc. (US) - Siemens Healthcare (Germany) - VuCOMP Inc. (US) Key Topics Covered: 1. OUTLOOK 2. MARKET OVERVIEW & TRENDS 3. COMPETITION 4. APPLICATIONS OF CAD 5. REGIONAL PERSPECTIVE 6. PRODUCT OVERVIEW 7. PRODUCT INNOVATIONS/INTRODUCTIONS 8. RECENT INDUSTRY ACTIVITY 9. FOCUS ON SELECT PLAYERS III. COMPETITIVE LANDSCAPE - Total Companies Profiled: 29 (including Divisions/Subsidiaries - 31) - The United States (21) - Japan (1) - Europe (
- - Germany (2) - - Italy (1) - - Spain (1) - - Rest of Europe (4) - Asia-Pacific (Excluding Japan) (1) For more information visit http://www.researchandmarkets.com/research/x4...uter_aided
ICAD: 10.73 (+0.21), MRGE: 6.04 (+0.06), HOLX: 33.99 (+0.57)
Fluoroscopy and Mobile C-Arms - 2015 Global Strategic Business Report
M2 - Tue Mar 24, 4:10AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8hvmm9/fluoroscopy_and) has announced the addition of the "Fluoroscopy and Mobile C-Arms - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Fluoroscopy and Mobile C-Arms in US$ Thousands by the following Segments: Fluoroscopy, and Mobile C-Arms (Full-Size C-Arms, & Mini C-Arms). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. The report profiles 31 companies including many key and niche players such as: - GE Healthcare (UK) - Hologic, Inc. (USA) - OrthoScan, Inc. (USA) - Philips Healthcare (The Netherlands) - Shimadzu Corp. (Japan) - Siemens Healthcare (Germany) - Toshiba Medical Systems Corp. (Japan) - Ziehm Imaging GmbH (Germany) Key Topics Covered: 1. MARKET OVERVIEW 2. GROWTH DRIVERS, MARKET TRENDS & ISSUES 3. MEDICAL IMAGING EQUIPMENT MARKET: AN OVERVIEW 4. PRODUCT OVERVIEW 5. SELECT MODELS OFFERED BY KEY COMPANIES 6. PRODUCT INTRODUCTIONS/INNOVATIONS 7. RECENT INDUSTRY ACTIVITY 8. FOCUS ON SELECT PLAYERS 9. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 31 (including Divisions/Subsidiaries - 39) - The United States (12) - Japan (4) - Europe (17) - - France (2) - - Germany (3) - - The United Kingdom (2) - - Italy (6) - - Spain (1) - - Rest of Europe (3) - Asia-Pacific (Excluding Japan) (4) - Latin America (1) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/8h...oscopy_and
HOLX: 33.99 (+0.57)
Leading 100 Medical Devices Companies of USA/Canada 2015
M2 - Mon Mar 23, 10:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9k2tjj/usacanada) has announced the addition of the "USA/Canada Medical Devices 100: An Industry Report" report to their offering. The United States is the largest medical device market in the world with a market size of around $110 billion, and it is expected to reach $133 billion by 2016 The U.S. market value represented about 38 percent of the global medical device market in 2012. The U.S. medical device companies are highly regarded globally for their innovations and high technology products. Canada's medical device market ranks as the ninth largest in the world. Canada has an estimated around $7 billion medical device market accounting for about 2 percent of the global market. The market is projected to increase at a CAGR of 4.0% to reach US$8.3bn by 2018. Around 80% of the market is supplied by imports, principally from the USA. With this special industry report, our endeavor is to provide the new investors with a complete resourceful research report for familiarizing with the present investment trends in USA/Canadian medical devices industry, which they would find beneficial to pursue for making business decisions in this sector. Report Highlights: - Leading 100 medical devices companies of USA/Canada - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances with foreign companies - International presence of USA/Canadian medical devices companies - R&D activities in the industry Report Includes Companies Engaged in: - Manufacturing medical equipments/devices that have life span of more than one year and that can be used repeatedly on multiple patients or multiple medical tests can be done by using them - Manufacturing medical devices providing any medical activity and/or treatment - Manufacturing diagnostic devices - Manufacturing high-tech medical instruments - Manufacturing life-support medical devices Key Features: - Financial information compiled from reliable primary and secondary sources - Business news and transactions compiled from primary news sources, company websites, and press releases - Original news source links provided for each news for further reference - Senior colleagues who analyze news have years of experience Companies Mentioned (Partial List) - Harvard Bioscience, Inc. (United States) - Hasco Medical, Incorporation (United States) - Heartware International Inc (United States) - HEI Inc (United States) - Hill-Rom Holdings, Incorporation (United States) - Hologic, Inc. (United States) - IDEXX Laboratories Inc (United States) - Illumina, Inc. (United States) - Imris Incorporation (Canada) - Inogen Inc (United States) - Insulet Corporation (United States) - Integra LifeSciences Holdings Corporation (United States) - Invacare Corporation (United States) - IRIDEX Corporation (United States) - Lifeline Scientific, Inc (United States) - Lifeloc Technologies Inc (United States) - Medifocus Inc (Canada) For more information visit http://www.researchandmarkets.com/research/9k2tjj/usacanada
IRIX: 10.02 (+0.19), ILMN: 189.59 (-3.01), HBIO: 6.22 (+0.08), PODD: 30.72 (+0.11), IART: 61.31 (+0.84), IVC: 20.68 (+0.14), IMRS: 0.69 (+0.04), INGN: 37.13 (+0.11), IDXX: 164.05 (+4.65), HRC: 51.94 (+0.03), HOLX: 33.99 (+0.57)
33.0% Return Seen to Date on SmarTrend Hologic Call (HOLX)
Comtex SmarTrend(R) - Mon Apr 20, 4:57PM CDT
SmarTrend identified an Uptrend for Hologic (NASDAQ:HOLX) on October 24th, 2014 at $24.87. In approximately 6 months, Hologic has returned 33.01% as of today's recent price of $33.08.
HOLX: 33.99 (+0.57)
Mammography Equipment (Analog & Digital) Market 2015-2020 - Global Strategic Business Report
M2 - Fri Apr 17, 3:49AM CDT
Research and Markets (http://www.researchandmarkets.com/research/svw6ds/mammography) has announced the addition of the "Mammography Equipment - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Mammography Equipment in US$ Thousands by the following Product Segments: Analog Mammography Equipment, and Digital Mammography Equipment. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. The report profiles 26 companies including many key and niche players such as: - Fujifilm Corporation (Japan) - GE Healthcare (The UK) - Hologic, Inc. (US) - I.M.S. (Internazional Medico Scientifica) srl (Italy) - Metaltronica SpA (Italy) - Philips Healthcare (The Netherlands) - Planmed Oy (Finland) - Siemens Healthcare (Germany) - Toshiba Medical Systems Corp. (Japan) Key Topics Covered: 1. INDUSTRY OVERVIEW 2. TRENDS AND ISSUES 3. 3D MAMMOGRAPHY MARKET 4. COMPETITIVE LANDSCAPE 5. MAMMOGRAPHY - AN OVERVIEW 6. COMPLEMENTARY CANCER DIAGNOSTIC TECHNOLOGIES 7. BREAST CANCER - A BACKDROP 8. PRODUCT INTRODUCTIONS/APPROVALS 9. RECENT INDUSTRY ACTIVITY 10. FOCUS ON SELECT PLAYERS 11. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 26 (including Divisions/Subsidiaries - 31) - The United States (15) - Canada (1) - Japan (3) - Europe (12) - - Germany (2) - - The United Kingdom (1) - - Rest of Europe (9) For more information visit http://www.researchandmarkets.com/research/sv...ammography
HOLX: 33.99 (+0.57)
Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology
PR Newswire - Thu Apr 16, 3:10PM CDT
Hologic, Inc. (NASDAQ: HOLX) today commented on an important cervical cancer screening studyi published on-line this week in Cancer Cytopathology, a peer-reviewed journal of the American Cancer Society.
HOLX: 33.99 (+0.57)
Cyberonics-Sorin $2.7B Deal Gets US Antitrust Go-Ahead - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 15, 1:30PM CDT
Cyberonics, Inc. (CYBX) declared that it has received the U.S. Antitrust go-ahead for the $2.7 billion deal.
ABMD: 68.83 (-0.74), LMNX: 16.10 (-0.18), HOLX: 33.99 (+0.57), CYBX: 62.89 (-0.30)
Is Great Basin Scientific Just Another Pump And Dump?
The GeoTeam - Seeking Alpha - Wed Apr 08, 12:57PM CDT
GeoInvesting is currently short Great Basic Scientific (NASDAQ: GBSN ), a rapid diagnostic medical test (Nucleic Acid Assay Testing) firm. We first alerted GeoInvesting premium members that we identified red flags associated with GBSN on March 30,...
GNMK: 10.69 (-0.24), GBSN: 4.17 (-0.53), BDX: 144.33 (-0.02), VIVO: 19.13 (+0.33), QDEL: 23.38 (-0.43), CPHD: 58.97 (+5.67), TTOO: 16.92 (-0.56), QGEN: 24.83 (-0.07), HOLX: 33.99 (+0.57), NSPH: 4.04 (+0.04)
Luxembourg National Health Laboratory Adopts Hologic's World Class Cervical Health Solutions for Screening Programme
PR Newswire Europe - Wed Apr 08, 2:00AM CDT
-- Improved sample quality, workflow efficiencies and flexibility drive transition to Hologic platform
HOLX: 33.99 (+0.57)
Diagnostic Imaging Technologies Global Market Report 2015 - Forecast to 2020
M2 - Tue Apr 07, 11:29AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dn9vr2/diagnostic) has announced the addition of the "Diagnostic Imaging Technologies Global Market - Forecast to 2020" report to their offering. The global diagnostic imaging market is expected to reach approximately $27.1 billion with a CAGR of 4.7% in coming five years. Diagnostic imaging is being identified as one of the fastest growing market of all healthcare sectors. Advances in diagnostic imaging technology have redefined how physicians diagnose and treat some of the most life threatening diseases such as cancer and heart disease and they have nearly eliminated the need for exploratory surgery. Imaging techniques would be therefore able us to diagnose, treat and cure patients without causing any harmful side effects. The different diagnostic imaging modalities include X-ray systems, Computed Tomography (CT) Scanners, Magnetic Resonance Imaging (MRI) systems, Ultrasound systems and Nuclear imaging systems. Globally among the diagnostic imaging techniques, X-ray is the most frequently used imaging procedure with more than 100 million X-ray exams per year followed by MRI, PET, SPECT, CT and nuclear medicine. This indicates that diagnostic imaging market contributes to its highest share among all imaging techniques. There are many factors involved in driving the growth of the diagnostic imaging market such as emerging applications in diagnostic procedures, high prevalence of the diseases, ongoing research activities all over the world and most important thing, awareness in people about the use of early disease diagnosis. On the other hand the high cost of the diagnostic imaging systems, risk of the radiation exposure, shortage of helium for MRI systems, poor healthcare insurance coverage, particularly for the diagnostic procedures are restricting the market growth. North America holds the largest share in the global diagnostic imaging market, followed by Europe. However, the Asia-Pacific market is expected to grow at the fastest CAGR in the coming five years. The Asian and Latin American countries represent the fastest growing markets due to increasing government support for research and rising industry and academic partnerships for pre-clinical research. But still the factors like economic slowdown, pricing pressures may compel the companies to focus on Asian markets. The top key market players in the global diagnostic imaging market are GE Healthcare, Philips Healthcare, Siemens Healthcare, Toshiba Medical Systems Corporation, Hitachi Medical Corporation, Carestream Health, Inc., Esaote S.P.A, Hologic, Inc., Samsung Medison and Shimadzu Corporation. Among them GE Healthcare (U.K.) held the leadership position in the global market by launching many new products into the market. Key Topics Covered: 1 Executive Summary 2 Introduction 3 Market Analysis 4 Diagnostic Imaging Technologies Global Market, By Products 5 Global Diagnostic Imaging Market, Technology Outlook 6 Diagnostic Imaging Technologies Global Market, Applications Outlook 7 Diagnostic Imaging Technologies Global Market, By End-Users 8 Regional Market Analysis 9 Company Developments 10 Major Player Profiles - Carestream Health, Inc. - Esaote S.P.A - GE Healthcare - Hitachi Medical Corporation - Hologic, Inc - Philips Healthcare - Samsung Medison - Shimadzu Corporation - Siemens Healthcare - Toshiba Medical Systems Corporation For more information visit http://www.researchandmarkets.com/research/dn9vr2/diagnostic
MDSY: 2.50 (-0.06), HOLX: 33.99 (+0.57)
Hologic to Announce Financial Results for the Second Quarter of Fiscal 2015 on Wednesday, April 29, 2015
PR Newswire - Mon Apr 06, 3:01PM CDT
Hologic, Inc. (NASDAQ: HOLX) announced today that the Company plans to release its operating results for the second quarter of fiscal 2015 on Wednesday, April 29, 2015, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time.
HOLX: 33.99 (+0.57)
Uptrend Call Working As Hologic Stock Rises 33.0% (HOLX)
Comtex SmarTrend(R) - Mon Apr 06, 10:10AM CDT
SmarTrend identified an Uptrend for Hologic (NASDAQ:HOLX) on October 24th, 2014 at $24.87. In approximately 5 months, Hologic has returned 33.01% as of today's recent price of $33.08.
HOLX: 33.99 (+0.57)
IDEXX Banks on Strong CAG, Global Growth Continues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 01, 3:15PM CDT
On Mar 31 2015, we issued an updated research report on IDEXX Laboratories, Inc. (IDXX).
ABMD: 68.83 (-0.74), EW: 138.33 (-3.59), IDXX: 164.05 (+4.65), HOLX: 33.99 (+0.57)
Hologic Delivers Notice that Holders of 2.00% Convertible Exchange Senior Notes Due 2037 are Eligible to Convert
PR Newswire - Wed Apr 01, 3:01PM CDT
Hologic, Inc. (NASDAQ: HOLX) announced today that it has notified holders of the 2.00% Convertible Exchange Senior Notes due 2037 (CUSIP No. 436440 AB7) issued November 23, 2010, and Wilmington Trust Company, the trustee, paying agent and conversion agent for the notes, that holders are eligible to convert the notes. This conversion right is subject to the terms of the base indenture governing the notes dated as of December 10, 2007, as supplemented by the second supplemental indenture dated as of November 23, 2010 (collectively, the indenture).
HOLX: 33.99 (+0.57)
Health Care Equipment Stocks Technical Data -- Boston Scientific, Abbott Laboratories, Zimmer Holdings, Hologic, and Accuray
PR Newswire - Wed Apr 01, 7:35AM CDT
Editor Note: For more information about this release, please scroll to bottom.
ZMH: 118.76 (+0.19), BSX: 18.34 (-0.08), ABT: 48.32 (-0.14), ARAY: 9.11 (-0.11), HOLX: 33.99 (+0.57)
Hologic Has Returned 32.0% Since SmarTrend Recommendation (HOLX)
Comtex SmarTrend(R) - Mon Mar 30, 9:24AM CDT
SmarTrend identified an Uptrend for Hologic (NASDAQ:HOLX) on October 24th, 2014 at $24.87. In approximately 5 months, Hologic has returned 31.97% as of today's recent price of $32.82.
HOLX: 33.99 (+0.57)
Zacks Industry Outlook Highlights: Boston Scientific, Edwards Lifesciences, Natus Medical, Hologic and Abiomed - Press Releases
Zacks Equity Research - Zacks Investment Research - Fri Mar 27, 8:30AM CDT
Zacks Industry Outlook Highlights: Boston Scientific, Edwards Lifesciences, Natus Medical, Hologic and Abiomed
BSX: 18.34 (-0.08), ABMD: 68.83 (-0.74), BABY: 42.15 (-0.01), EW: 138.33 (-3.59), HOLX: 33.99 (+0.57)
MedTech M&As Continue Regardless of Tax Scenarios - Industry Outlook
Zacks Equity Research - Zacks Investment Research - Thu Mar 26, 3:28PM CDT
MedTech M&As Continue Regardless of Tax Scenarios - Industry Outlook
ABMD: 68.83 (-0.74), BDX: 144.33 (-0.02), MDT: 77.61 (-0.89), ILMN: 189.59 (-3.01), TRNX: 26.25 (+0.01), ARAY: 9.11 (-0.11), NUVA: 43.99 (+0.23), HSP: 87.61 (-0.05), BSX: 18.34 (-0.08), BABY: 42.15 (-0.01), SNN: 35.76 (+0.44), JNJ: 101.08 (+0.62), WMGI: 26.26 (-0.03), IART: 61.31 (+0.84), SWM: 45.62 (+0.16), SYK: 96.90 (-0.28), ZMH: 118.76 (+0.19), ABT: 48.32 (-0.14), ALGN: 59.18 (+3.17), EW: 138.33 (-3.59), MYL: 76.06 (+2.37), ABAX: 63.62 (+0.31), STE: 70.76 (+0.06), GILD: 103.69 (-1.52), BAX: 71.14 (-0.37), DGX: 75.81 (+0.60), STJ: 73.47 (-0.54), LH: 126.93 (+0.55), HOLX: 33.99 (+0.57)
Computer Aided Detection (CAD) - Global Strategic Business Report 2015-2020: CAD Use Rises despite Controversies
M2 - Thu Mar 26, 6:32AM CDT
Research and Markets (http://www.researchandmarkets.com/research/x45l84/computer_aided) has announced the addition of the "Computer Aided Detection (CAD) - Global Strategic Business Report" report to their offering. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. This report analyzes the US and European markets for Computer Aided Detection (CAD) in US$ Thousands by the following Application Segments - Breast, Chest, and Others. The US market is also analysed in Number of Units for the above Application Segments. The report also provides a consolidated, single-segment volume analysis for the European market. The report profiles 29 companies including many key and niche players such as: - EDDA Technology, Inc. (US) - Hologic, Inc. (US) - iCAD, Inc. (US) - Invivo Corp. (US) - Merge Healthcare, Inc. (US) - Riverain Technologies (US) - Salient Imaging, Inc. (US) - Siemens Healthcare (Germany) - VuCOMP Inc. (US) Key Topics Covered: 1. OUTLOOK 2. MARKET OVERVIEW & TRENDS 3. COMPETITION 4. APPLICATIONS OF CAD 5. REGIONAL PERSPECTIVE 6. PRODUCT OVERVIEW 7. PRODUCT INNOVATIONS/INTRODUCTIONS 8. RECENT INDUSTRY ACTIVITY 9. FOCUS ON SELECT PLAYERS III. COMPETITIVE LANDSCAPE - Total Companies Profiled: 29 (including Divisions/Subsidiaries - 31) - The United States (21) - Japan (1) - Europe (
- - Germany (2) - - Italy (1) - - Spain (1) - - Rest of Europe (4) - Asia-Pacific (Excluding Japan) (1) For more information visit http://www.researchandmarkets.com/research/x4...uter_aided ICAD: 10.73 (+0.21), MRGE: 6.04 (+0.06), HOLX: 33.99 (+0.57)
Fluoroscopy and Mobile C-Arms - 2015 Global Strategic Business Report
M2 - Tue Mar 24, 4:10AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8hvmm9/fluoroscopy_and) has announced the addition of the "Fluoroscopy and Mobile C-Arms - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Fluoroscopy and Mobile C-Arms in US$ Thousands by the following Segments: Fluoroscopy, and Mobile C-Arms (Full-Size C-Arms, & Mini C-Arms). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. The report profiles 31 companies including many key and niche players such as: - GE Healthcare (UK) - Hologic, Inc. (USA) - OrthoScan, Inc. (USA) - Philips Healthcare (The Netherlands) - Shimadzu Corp. (Japan) - Siemens Healthcare (Germany) - Toshiba Medical Systems Corp. (Japan) - Ziehm Imaging GmbH (Germany) Key Topics Covered: 1. MARKET OVERVIEW 2. GROWTH DRIVERS, MARKET TRENDS & ISSUES 3. MEDICAL IMAGING EQUIPMENT MARKET: AN OVERVIEW 4. PRODUCT OVERVIEW 5. SELECT MODELS OFFERED BY KEY COMPANIES 6. PRODUCT INTRODUCTIONS/INNOVATIONS 7. RECENT INDUSTRY ACTIVITY 8. FOCUS ON SELECT PLAYERS 9. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 31 (including Divisions/Subsidiaries - 39) - The United States (12) - Japan (4) - Europe (17) - - France (2) - - Germany (3) - - The United Kingdom (2) - - Italy (6) - - Spain (1) - - Rest of Europe (3) - Asia-Pacific (Excluding Japan) (4) - Latin America (1) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/8h...oscopy_and
HOLX: 33.99 (+0.57)
Leading 100 Medical Devices Companies of USA/Canada 2015
M2 - Mon Mar 23, 10:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9k2tjj/usacanada) has announced the addition of the "USA/Canada Medical Devices 100: An Industry Report" report to their offering. The United States is the largest medical device market in the world with a market size of around $110 billion, and it is expected to reach $133 billion by 2016 The U.S. market value represented about 38 percent of the global medical device market in 2012. The U.S. medical device companies are highly regarded globally for their innovations and high technology products. Canada's medical device market ranks as the ninth largest in the world. Canada has an estimated around $7 billion medical device market accounting for about 2 percent of the global market. The market is projected to increase at a CAGR of 4.0% to reach US$8.3bn by 2018. Around 80% of the market is supplied by imports, principally from the USA. With this special industry report, our endeavor is to provide the new investors with a complete resourceful research report for familiarizing with the present investment trends in USA/Canadian medical devices industry, which they would find beneficial to pursue for making business decisions in this sector. Report Highlights: - Leading 100 medical devices companies of USA/Canada - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances with foreign companies - International presence of USA/Canadian medical devices companies - R&D activities in the industry Report Includes Companies Engaged in: - Manufacturing medical equipments/devices that have life span of more than one year and that can be used repeatedly on multiple patients or multiple medical tests can be done by using them - Manufacturing medical devices providing any medical activity and/or treatment - Manufacturing diagnostic devices - Manufacturing high-tech medical instruments - Manufacturing life-support medical devices Key Features: - Financial information compiled from reliable primary and secondary sources - Business news and transactions compiled from primary news sources, company websites, and press releases - Original news source links provided for each news for further reference - Senior colleagues who analyze news have years of experience Companies Mentioned (Partial List) - Harvard Bioscience, Inc. (United States) - Hasco Medical, Incorporation (United States) - Heartware International Inc (United States) - HEI Inc (United States) - Hill-Rom Holdings, Incorporation (United States) - Hologic, Inc. (United States) - IDEXX Laboratories Inc (United States) - Illumina, Inc. (United States) - Imris Incorporation (Canada) - Inogen Inc (United States) - Insulet Corporation (United States) - Integra LifeSciences Holdings Corporation (United States) - Invacare Corporation (United States) - IRIDEX Corporation (United States) - Lifeline Scientific, Inc (United States) - Lifeloc Technologies Inc (United States) - Medifocus Inc (Canada) For more information visit http://www.researchandmarkets.com/research/9k2tjj/usacanada
IRIX: 10.02 (+0.19), ILMN: 189.59 (-3.01), HBIO: 6.22 (+0.08), PODD: 30.72 (+0.11), IART: 61.31 (+0.84), IVC: 20.68 (+0.14), IMRS: 0.69 (+0.04), INGN: 37.13 (+0.11), IDXX: 164.05 (+4.65), HRC: 51.94 (+0.03), HOLX: 33.99 (+0.57)
